HK1224175A1 - 用於減少痂形成並促進癒合的組合物 - Google Patents

用於減少痂形成並促進癒合的組合物

Info

Publication number
HK1224175A1
HK1224175A1 HK16109680.8A HK16109680A HK1224175A1 HK 1224175 A1 HK1224175 A1 HK 1224175A1 HK 16109680 A HK16109680 A HK 16109680A HK 1224175 A1 HK1224175 A1 HK 1224175A1
Authority
HK
Hong Kong
Prior art keywords
composition
promoting healing
scab formation
reducing scab
reducing
Prior art date
Application number
HK16109680.8A
Other languages
English (en)
Inventor
比吉塔．斯文森
洛塔．林賽福爾斯
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of HK1224175A1 publication Critical patent/HK1224175A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16109680.8A 2013-04-26 2016-08-12 用於減少痂形成並促進癒合的組合物 HK1224175A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1350518 2013-04-26
PCT/SE2014/050487 WO2014175814A1 (en) 2013-04-26 2014-04-23 Composition for use in reducing scab formation and promoting healing

Publications (1)

Publication Number Publication Date
HK1224175A1 true HK1224175A1 (zh) 2017-08-18

Family

ID=51792217

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16109680.8A HK1224175A1 (zh) 2013-04-26 2016-08-12 用於減少痂形成並促進癒合的組合物

Country Status (10)

Country Link
US (1) US20160081968A1 (zh)
EP (1) EP2988731B1 (zh)
CN (1) CN105338963A (zh)
AU (1) AU2014257984B2 (zh)
BR (1) BR112015027026A8 (zh)
CA (1) CA2910114A1 (zh)
ES (1) ES2860578T3 (zh)
HK (1) HK1224175A1 (zh)
PL (1) PL2988731T3 (zh)
WO (1) WO2014175814A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
KR20190097003A (ko) * 2016-12-16 2019-08-20 에이에이케이 아베 (파블) 페트롤라툼 대체 제제
FI3628002T3 (fi) * 2017-05-23 2023-05-15 Pharmiva Ab Vaahtoa muodostavat koostumukset aktiivisen aineen kuljettamiseksi kehon onteloon
CN108697629B (zh) * 2017-09-05 2021-10-15 拉芳家化股份有限公司 一种天然替代的植物精油防腐剂及在化妆品中的应用
WO2020040769A1 (en) * 2018-08-23 2020-02-27 Elorac, Inc. Method and compositions for alleviating keratoconjunctivitis sicca
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca
JP2024522372A (ja) * 2021-06-11 2024-06-18 アンク、ライフ、サイエンシズ、リミテッド 有効薬剤の組合せの局所送達のための安定性が向上した脂質結晶性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297511A (zh) * 1956-12-20
DK116528A (zh) * 1966-09-30
WO1982003173A1 (en) * 1981-03-17 1982-09-30 Bo Thuresson Ekenstam A germicidal composition
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
WO1995026715A2 (en) * 1994-03-30 1995-10-12 Dumex-Alpharma A/S Use of fatty acid esters as bioadhesive substances
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof

Also Published As

Publication number Publication date
ES2860578T3 (es) 2021-10-05
BR112015027026A8 (pt) 2018-01-30
CN105338963A (zh) 2016-02-17
WO2014175814A1 (en) 2014-10-30
EP2988731A4 (en) 2016-05-18
CA2910114A1 (en) 2014-10-30
US20160081968A1 (en) 2016-03-24
BR112015027026A2 (pt) 2017-07-25
PL2988731T3 (pl) 2021-08-02
EP2988731B1 (en) 2021-02-17
AU2014257984A1 (en) 2015-11-12
AU2014257984B2 (en) 2019-07-11
EP2988731A1 (en) 2016-03-02

Similar Documents

Publication Publication Date Title
HK1217651A1 (zh) 固溶體組合物及其在劇痛中的用途
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
GB201317286D0 (en) Composition and Use
HK1224175A1 (zh) 用於減少痂形成並促進癒合的組合物
PL3004108T3 (pl) Pochodne pirazolo-pirolidyn-4-onu jako inhibitory BET oraz ich zastosowanie w leczeniu chorób
GB201407698D0 (en) Improvements in and relating to ophthalmo-scopes
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
HRP20170198T1 (hr) Pripravci koji sadrže kondroitin-sulfat, natokinazu i sulfhidrilne spojeve za upotrebu u liječenju upale
HK1223906A1 (zh) 用於建築材料的鳥糞石- 及鉀石膏組合物
IL245015A0 (en) Medicinal composition containing icotinib for topical treatment of the skin and its use
GB201308753D0 (en) Compounds and their use in therapy
HK1208360A1 (zh) 創傷癒合組合物及其用途
EP2968398A4 (en) MODIFIED HYALURONAN AND USES THEREOF IN CANCER TREATMENT
GB201308217D0 (en) Compounds and their use in therapy
ZA201408732B (en) Composition and methods for treating wounds
GB201320958D0 (en) Improvements in and relating to medical devices
GB201314623D0 (en) Novel mucinase for use in therapy or prophylaxis
GB201312129D0 (en) Drug combination and its use in therapy
GB201312128D0 (en) Drug combination and its use in therapy
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB201322467D0 (en) Composition and use